Frontiers | Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory fail
Interleukin-6 and C-reactive protein/albumin ratio as predictors of COVID-19 severity and mortality | The Egyptian Journal of Bronchology | Full Text
Assessing the importance of interleukin-6 in COVID-19 – Authors' reply - The Lancet Respiratory Medicine
The role of Interleukin 6 inhibitors in therapy of severe COVID-19 - ScienceDirect
Role of initial and follow-up IL-6 (Interleukin-6) titre in COVID-19 pneumonia: A single center experience
Frontiers | Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis
Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19 | PLOS ONE
The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019 | EMBO Molecular Medicine
IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections | PLOS Pathogens
Frontiers | Future Biomarkers for Infection and Inflammation in Febrile Children
Modifications of IL-6 by Hypochlorous Acids: Effects on Receptor Binding | ACS Omega
Circulating interleukin 6 and interleukin 10 in community acquired pneumonia | Thorax
ACEP // Laboratory Abnormalities
COVID | Free Full-Text | Follow-up of Interleukin 6 and Other Blood Markers during the Hospitalization of COVID-19 Patients: A Single-Center Study
Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine
Outlook of IL-6 signaling blockade for COVID-19 pneumonia | Inflammation and Regeneration | Full Text
The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019 | EMBO Molecular Medicine
Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19 | Circulation Research
IL (Interleukin)-6 Contributes to Deep Vein Thrombosis and Is Negatively Regulated by miR-338-5p | Arteriosclerosis, Thrombosis, and Vascular Biology
Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients | Cell Death Discovery
An inflammatory cytokine signature predicts COVID-19 severity and survival | Nature Medicine
COVID | Free Full-Text | Follow-up of Interleukin 6 and Other Blood Markers during the Hospitalization of COVID-19 Patients: A Single-Center Study
Frontiers | Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
Toward the Rapid Diagnosis of Sepsis: Detecting Interleukin-6 in Blood Plasma Using Functionalized Screen-Printed Electrodes with a Thermal Detection Methodology | Analytical Chemistry
Systemic cytokine levels in community-acquired pneumonia and their association with disease severity | European Respiratory Society
Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019 | Cellular & Molecular Immunology
